Article: Advanced Viral Research Announces Private Placement; Company Leases New Headquarters and Laboratory Space

NEW YORK, March 4 /PRNewswire/ -- Advanced Viral Research Corp. (Nasdaq-BB: ADVR) today announced the completion of a private placement in the form of a 7% ten year convertible debenture to the RBB Bank of Austria. The debenture is convertible into shares of common stock at 70 percent of the average closing prices for the five consecutive trading days before the conversion date. In addition, the company issued to RBB Bank warrants to purchase an aggregate of 535,134 common shares (approximately 2/10 of 1 percent of outstanding shares) at prices ranging from $.29 to $.84 per share, in an offshore transaction pursuant to Regulation S of the Securities Act of 1933. The ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!